Regenxbio INC. (RGNX) SEC Filings — 2024
21 SEC filings for Regenxbio INC. (RGNX) in 2024.
Filings
- REGENXBIO Inc. Files 8-K Report — 8-K · Dec 9, 2024
- Regenxbio INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Regenxbio INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- REGENXBIO Q3 Update: $574.8M Cash, R&D Spends Rise — 10-Q · Nov 6, 2024
- Regenxbio INC. SC 13G/A Filing — SC 13G/A · Nov 4, 2024
- Regenxbio INC. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- REGENXBIO Inc. Files 8-K: Officer/Director Changes & Compensation — 8-K · Sep 17, 2024
- REGENXBIO Appoints New CSO, Dr. Gregory — 8-K · Aug 6, 2024
- REGENXBIO Inc. Files Q2 2024 10-Q Report — 10-Q · Aug 1, 2024
- REGENXBIO Appoints New Chief Medical Officer — 8-K · Jun 13, 2024
- REGENXBIO Files 8-K on Shareholder Votes and Financials — 8-K · Jun 3, 2024
- REGENXBIO Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- REGENXBIO Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · Apr 4, 2024
- REGENXBIO Files 8-K: Other Events & Exhibits — 8-K · Mar 11, 2024
- REGENXBIO Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 27, 2024
- Regenxbio INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Regenxbio INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- GIC Cuts REGENXBIO Stake to 8.0% as of Dec 31, 2023 — SC 13G/A · Feb 5, 2024
- State Street Amends REGENXBIO Stake, Maintains Passive Position — SC 13G/A · Jan 25, 2024
- JPMorgan Amends REGENXBIO Stake; Ownership Update Filed — SC 13G/A · Jan 25, 2024
- BlackRock Amends REGENXBIO Stake, Signals Continued Institutional Confidence — SC 13G/A · Jan 19, 2024